Show
Sort by
-
- Journal Article
- A1
- open access
GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
-
- Journal Article
- A1
- open access
An unexpected encounter : respiratory syncytial virus nonstructural protein 1 interacts with mediator subunit MED25
-
- Journal Article
- A1
- open access
How RSV proteins join forces to overcome the host innate immune response
-
GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery
-
- Journal Article
- A1
- open access
Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
-
- Journal Article
- A1
- open access
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models
-
- Journal Article
- A1
- open access
In vivo therapy with M2e-specific IgG selects for an influenza A virus mutant with delayed matrix protein 2 expression
-
A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody
-
Single-domain antibodies make a difference
-
- Journal Article
- A1
- open access
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
-
- Journal Article
- A1
- open access
mRNA encoding a bispecific single domain antibody construct protects against influenza A virus infection in mice
-
Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies
-
Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies (vol 181, pg 1004, 2020)
-
- Journal Article
- A1
- open access
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
-
- Journal Article
- A1
- open access
Respiratory syncytial virus nonstructural proteins 1 and 2 : exceptional disrupters of innate immune responses
-
- Journal Article
- A1
- open access
Selective engagement of FcγRIV by a M2e-specific single domain antibody construct protects against influenza A virus infection
-
- Journal Article
- A1
- open access
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
-
Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses
-
- Journal Article
- A1
- open access
Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
-
A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7.
-
- Journal Article
- A2
- open access
Single-domain antibodies and their formatting to combat viral infections
-
Transiently thermoresponsive acetal polymers for safe and effective administration of Amphotericin B as a vaccine adjuvant
-
- Journal Article
- A1
- open access
A respiratory syncytial virus vaccine based on the small hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults : a first-in-humans study
-
Vaccine options for influenza : thinking small
-
- Journal Article
- A1
- open access
Removal of the N-glycosylation sequon at position N116 located in p27 of the respiratory syncytial virus fusion protein elicits enhanced antibody responses after DNA immunization
-
Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice
-
- Journal Article
- A1
- open access
Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ
-
Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
-
Clinical potential of prefusion RSV F-specific antibodies
-
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection
-
M2-based influenza vaccines : recent advances and clinical potential
-
- Miscellaneous
- open access
IgG3 snitcher of RSV infections in the very young
-
- Journal Article
- A1
- open access
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
-
Hierarchical and redundant roles of activating FcγRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies
-
Regulation of kynurenine biosynthesis during influenza virus infection
-
Phosphoproteomics to characterize host response during influenza A virus infection of human macrophages
-
- Journal Article
- A1
- open access
Long-lasting cross-protection against influenza A by neuraminidase and M2e-based immunization strategies
-
Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination
-
GM-CSF treatment prevents respiratory syncytial virus– induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation
-
Crystal structure of the conserved amino terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody
-
The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice
-
- Journal Article
- A1
- open access
Developing 3D SEM in a broad biological context
-
Scop3D : three-dimensional visualization of sequence conservation
-
- Journal Article
- A1
- open access
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody
-
Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody
-
Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen
-
- Journal Article
- A1
- open access
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
-
CD8⁺ T cell immunity against human respiratory syncytial virus
-
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge
-
Presenting heterologous epitopes with hepatitis B core-based virus-like particles